Natural immunity is the protection created by the body against an invading germ after it has caused an infection. Typically this is associated with the production of antibodies against the germ, but there is much more involved in the protection the immune system provides the human organism. For months the role of natural immunity was ignored or denied in the Covid narrative; this finally appeared to change only in Jan 2022 with a CDC publication on risks of SARS-CoV-2 infection in vaccinated and previously infected individuals (1). Yet in October 2021 Paul Alexander published a list of 150 studies attesting to natural immunity (2).

PANDA - INFOBANK - NATURAL IMMUNITY

The human immune system is one of the most sophisticated achievements of evolution. The survival of our species has depended on it for millennia. And today, we are still very much relying on it. Even vaccines depend entirely on the immune system: vaccines essentially teach our immune systems what viral markers to be prepared for, they are not cures per se. Without a functional immune system, there can be no effective vaccine. 1)

NATURAL IMMUNITY VS VACCINE-INDUCED IMMUNITY

Natural Immunity and vaccine-induced immunity build on the same underlying biological processes. As such they might be perceived to be equivalent, yet they aren’t – at least not to this day.

Some authorities have suggested that vaccines induce better immunity than natural immunisation following an infection. Beyond the evolutionary inconsistency of such a narrative, this statement has been disproven by multiple studies [1,2,3,4,5]. It is also visible to all that virus infections have not abated despite wide vaccination coverage throughout the world, and today the vast majority of repeat infections are in the most vaccinated countries.

  • 1. . Natural immunity is superior to vaccine-induced …stating otherwise is disinformation
  • M. Girardot, Covid Myth Buster Series, February 2022
  • 2. Comparing SARS-CoV-2 natural immunity to vaccine-induced immunity: reinfections versus breakthrough infections
  • Gazit et al, August 2021
  • 3. SARS-CoV-2 Naturally Acquired Immunity vs. Vaccine-induced Immunity, Reinfections versus Breakthrough Infections: a Retrospective Cohort Study
  • Gazit et al, April 2022
  • 4. Longitudinal analysis shows durable and broad immune memory after SARS-CoV-2 infection with persisting antibody responses and memory B and T cells
  • K. W. Cohen et al, June 2021
  • 5. Duration of immune protection of SARS-CoV-2 natural infection against reinfection in Qatar
  • Chemaitelly et al, July 2022

EFFICACY OF COVID VACCINES

Today’s implementations of COVID vaccines have proven to be no match for the kind of immunity provided by natural immunisation – these vaccines are not sterilising and therefore do not stop transmission. Additionally, the current vaccines have shown to have very dubious efficacy, as the vaccinated and unvaccinated carry similar viral loads when infected [6,7,8,9].

This should not come as a surprise to those who study virology and immunology: SARS-CoV is a mucosal virus that essentially propagates in the mucus, notably in the lungs. Stimulating an immune reaction in the mucus by injecting a product – however novel – in the deltoid muscle seems incongruous at best, if not totally illusory.

Over the past 30 years, many scientists have denounced the fallacy of an intramuscular vaccination to tackle mucosal viruses [10,11,12,13] such as the flu or Coronas. Mucosal vaccines that provide any form of preemptive immunity have yet to come to market.

  • 6. No Significant Difference in Viral Load Between Vaccinated and Unvaccinated, Asymptomatic and Symptomatic Groups When Infected with SARS-CoV-2 Delta Variant
  • Acharya et al, October 2021
  • 7. Isolation of 4000 SARS-CoV-2 shows that contagiousness is associated with viral load, not vaccine or symptomatic status
  • Boschi et al, July 2022 [December 2021]
  • 8. Vaccinated and unvaccinated individuals have similar viral loads in communities with a high prevalence of the SARS-CoV-2 delta variant
  • Riemersma et al, July 2021
  • 9. Predominance of antibody-resistant SARS-CoV-2 variants in vaccine breakthrough cases from the San Francisco Bay
  • Servellita et al, January 2022
  • 10. Can a shot in the deltoid stimulate mucus in the airways? The answer is “No” … Then, how can vaccines be effective?
  • M. Girardot, Covid Myth Buster Series, January 2022
  • 11. Why intramuscular COVID-19 vaccination must fail
  • S. Bhakdi et al, October 2021
  • 12. Mucosal Immunity in COVID-19: A Neglected but Critical Aspect of SARS-CoV-2 Infection
  • M. W. Russell et al, November 2020
  • 13. The mucosal immune system: from fundamental concepts to vaccine development
  • J. R. McGhee et al, 1992

News stories

Print/export